Spectrum Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 3/6
Spectrum Pharmaceuticals has a total shareholder equity of $26.8M and total debt of $28.8M, which brings its debt-to-equity ratio to 107.6%. Its total assets and total liabilities are $107.7M and $80.9M respectively.
Key information
107.6%
Debt to equity ratio
US$28.84m
Debt
| Interest coverage ratio | n/a |
| Cash | US$56.14m |
| Equity | US$26.81m |
| Total liabilities | US$80.87m |
| Total assets | US$107.68m |
Recent financial health updates
Is Spectrum Pharmaceuticals (NASDAQ:SPPI) In A Good Position To Invest In Growth?
Sep 16
Here's Why We're A Bit Worried About Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation
Jun 04Recent updates
Analysts Just Made A Huge Upgrade To Their Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Forecasts
May 14Earnings Update: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Just Reported And Analysts Are Boosting Their Estimates
May 12Spectrum plunges 28% after FDA scientists question poziotinib evidence for NSCLC
Sep 20Is Spectrum Pharmaceuticals (NASDAQ:SPPI) In A Good Position To Invest In Growth?
Sep 16Spectrum Pharmaceuticals stock jumps 10% afterhours on FDA nod for Rolvedon injection
Sep 09Spectrum Pharmaceuticals: Revisiting This 'Soap Opera'
Aug 21Spectrum Pharmaceuticals Q2 2022 Earnings Preview
Aug 10Here's Why We're A Bit Worried About Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation
Jun 04Spectrum Pharmaceuticals: Some Last Words
Feb 25Here's Why We're Watching Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation
Oct 05Spectrum Pharmaceuticals' CRL: There Is Very Little Clarity
Aug 12Spectrum's Big Approval: Any Day Now
Jul 29FDA initiates pre-approval inspection for Spectrum pharmaceuticals' ROLONTIS
Jun 01Here's Why We're Watching Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation
May 31We're Keeping An Eye On Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Rate
Feb 12Spectrum Pharma drops after announcing less-than-favorable Phase 2 data
Dec 22Here's What Spectrum Pharmaceuticals, Inc.'s (NASDAQ:SPPI) Shareholder Ownership Structure Looks Like
Dec 21Spectrum Pharma Is Down But Not Out
Nov 16Spectrum Shareholders In Limbo As FDA Delays Rolontis Decision Date, Agrees To Discuss Poziotinib
Nov 11Financial Position Analysis
Short Term Liabilities: SPPI's short term assets ($105.4M) exceed its short term liabilities ($38.9M).
Long Term Liabilities: SPPI's short term assets ($105.4M) exceed its long term liabilities ($42.0M).
Debt to Equity History and Analysis
Debt Level: SPPI has more cash than its total debt.
Reducing Debt: SPPI's debt to equity ratio has increased from 12% to 107.6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SPPI has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if SPPI has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.